• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗马尼亚的帕金森病:一项范围综述

Parkinson's Disease in Romania: A Scoping Review.

作者信息

Rosca Elena Cecilia, Tudor Raluca, Cornea Amalia, Simu Mihaela

机构信息

Department of Neurology, Victor Babes University of Medicine and Pharmacy of Timisoara, Eftimie Murgu Sq. No. 2, 300041 Timișoara, Romania.

Department of Neurology, Clinical Emergency County Hospital Timisoara, Bd. Iosif Bulbuca No. 10, 300736 Timisoara, Romania.

出版信息

Brain Sci. 2021 May 27;11(6):709. doi: 10.3390/brainsci11060709.

DOI:10.3390/brainsci11060709
PMID:34071802
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8226866/
Abstract

Parkinson's disease (PD) is a significant cause of disability, with a fast-growing prevalence. This review summarizes the epidemiological and clinical data, research on the diagnostic approaches and the interventions available in the Eastern European country of Romania. This scoping review follows the recommendations on the scoping review methodology by Joanna Briggs Institute. We searched four databases (up to 27 January 2021). The data of eligible studies were extracted in standardized forms. We identified 149 unique studies from 1133 records, with 11 epidemiological studies, 52 studies investigating clinical aspects of PD, 35 studies on diagnostic tools, and 51 intervention studies. A narrative synthesis is provided and placed in a historical context. Our review revealed a considerable increase in the Romanian research on PD in the latest 15 years, which largely follows international trends. However, we also identified several research gaps that provide useful information for policymakers, public health specialists, and clinicians.

摘要

帕金森病(PD)是导致残疾的一个重要原因,其患病率正在迅速上升。本综述总结了东欧国家罗马尼亚的流行病学和临床数据、诊断方法研究以及可用干预措施。本范围综述遵循乔安娜·布里格斯研究所关于范围综述方法的建议。我们检索了四个数据库(截至2021年1月27日)。符合条件的研究数据以标准化形式提取。我们从1133条记录中识别出149项独特研究,其中11项为流行病学研究,52项研究帕金森病的临床方面,35项关于诊断工具的研究,以及51项干预研究。我们进行了叙述性综合分析,并将其置于历史背景中。我们的综述显示,罗马尼亚在过去15年中对帕金森病的研究有了显著增加,这在很大程度上遵循了国际趋势。然而,我们也发现了几个研究空白,可为政策制定者、公共卫生专家和临床医生提供有用信息。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/802f7909a7ac/brainsci-11-00709-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/ccac3213998d/brainsci-11-00709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/cc8eb38ca994/brainsci-11-00709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/506b3e46361c/brainsci-11-00709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/23a77bb73ac2/brainsci-11-00709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/ecccb9fd998a/brainsci-11-00709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/d702db0eb8da/brainsci-11-00709-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/4d1e24a799ed/brainsci-11-00709-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/802f7909a7ac/brainsci-11-00709-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/ccac3213998d/brainsci-11-00709-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/cc8eb38ca994/brainsci-11-00709-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/506b3e46361c/brainsci-11-00709-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/23a77bb73ac2/brainsci-11-00709-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/ecccb9fd998a/brainsci-11-00709-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/d702db0eb8da/brainsci-11-00709-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/4d1e24a799ed/brainsci-11-00709-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1bc/8226866/802f7909a7ac/brainsci-11-00709-g008.jpg

相似文献

1
Parkinson's Disease in Romania: A Scoping Review.罗马尼亚的帕金森病:一项范围综述
Brain Sci. 2021 May 27;11(6):709. doi: 10.3390/brainsci11060709.
2
Parkinson's Disease in Romania: A Scoping Review Protocol.罗马尼亚的帕金森病:一项范围综述方案
Brain Sci. 2021 Feb 17;11(2):251. doi: 10.3390/brainsci11020251.
3
Exploring public perceptions and awareness of Parkinson's disease: A scoping review.探索公众对帕金森病的认知和意识:范围综述。
PLoS One. 2023 Sep 15;18(9):e0291357. doi: 10.1371/journal.pone.0291357. eCollection 2023.
4
Exploring Parkinson's disease prevalence in regional, rural and remote Australia: A systematic scoping review.探讨澳大利亚地区、农村和偏远地区帕金森病的患病率:系统范围综述。
Aust J Rural Health. 2023 Dec;31(6):1156-1167. doi: 10.1111/ajr.13054. Epub 2023 Oct 27.
5
Parkinson's disease: a scoping review of the quantitative and qualitative evidence of its diagnostic accuracy in primary care.帕金森病:初级保健中其诊断准确性的定量和定性证据的范围综述。
Br J Gen Pract. 2024 Mar 27;74(741):e227-e232. doi: 10.3399/BJGP.2023.0409. Print 2024 Apr.
6
Ethics of Procuring and Using Organs or Tissue from Infants and Newborns for Transplantation, Research, or Commercial Purposes: Protocol for a Bioethics Scoping Review.从婴儿和新生儿获取器官或组织用于移植、研究或商业目的的伦理问题:生物伦理学范围审查方案
Wellcome Open Res. 2024 Dec 5;9:717. doi: 10.12688/wellcomeopenres.23235.1. eCollection 2024.
7
Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.针对多病共存和多种药物治疗的老年人减药:TAILOR 证据综合。
Health Technol Assess. 2022 Jul;26(32):1-148. doi: 10.3310/AAFO2475.
8
Non-pharmacological rehabilitation for people living with advanced Parkinson's disease: A scoping review of interventions.晚期帕金森病患者的非药物康复:干预措施的范围综述
Parkinsonism Relat Disord. 2025 Apr;133:107317. doi: 10.1016/j.parkreldis.2025.107317. Epub 2025 Feb 4.
9
Experiences of people with Parkinson's disease and their views on physical activity interventions: a qualitative systematic review.帕金森病患者的经历及其对体育活动干预的看法:一项定性系统评价
JBI Database System Rev Implement Rep. 2019 Apr;17(4):548-613. doi: 10.11124/JBISRIR-2017-003901.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson's disease patients.在一大群晚期帕金森病患者中,从开始就使用 24 小时左旋多巴卡比多巴肠凝胶。
Sci Rep. 2024 Feb 14;14(1):3676. doi: 10.1038/s41598-024-54299-z.
2
Effects of COVID-19 on malaria elimination initiatives in sub-Saharan Africa: a scoping review protocol.COVID-19 对撒哈拉以南非洲消除疟疾倡议的影响:范围综述方案。
BMJ Open. 2023 Oct 11;13(10):e076140. doi: 10.1136/bmjopen-2023-076140.
3
Subarachnoid Hemorrhage in Patients with SARS-CoV-2 Infection: Protocol for A Scoping Review.

本文引用的文献

1
Parkinson's disease.帕金森病。
Lancet. 2021 Jun 12;397(10291):2284-2303. doi: 10.1016/S0140-6736(21)00218-X. Epub 2021 Apr 10.
2
Parkinson's Disease in Romania: A Scoping Review Protocol.罗马尼亚的帕金森病:一项范围综述方案
Brain Sci. 2021 Feb 17;11(2):251. doi: 10.3390/brainsci11020251.
3
Intrajejunal vs oral levodopa-carbidopa therapy in Parkinson disease: A retrospective cohort study.帕金森病中经空肠内与口服左旋多巴-卡比多巴治疗的比较:一项回顾性队列研究。
2019冠状病毒病感染患者的蛛网膜下腔出血:一项范围综述方案
Brain Sci. 2022 Sep 30;12(10):1327. doi: 10.3390/brainsci12101327.
4
Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease: Observations and Dilemmas after 10 Years of Real-Life Experience.左旋多巴-卡比多巴肠凝胶治疗晚期帕金森病:10年真实世界经验后的观察与困境
Pharmaceutics. 2022 May 24;14(6):1115. doi: 10.3390/pharmaceutics14061115.
5
Advanced Parkinson's Disease Treatment Simplification and Long-Term Outcomes with Levodopa Carbidopa Intestinal Gel: COSMOS Romanian Subanalysis.左旋多巴卡比多巴肠凝胶用于晚期帕金森病治疗简化及长期疗效:COSMOS罗马尼亚亚组分析
Brain Sci. 2021 Nov 27;11(12):1566. doi: 10.3390/brainsci11121566.
Medicine (Baltimore). 2020 Nov 13;99(46):e23249. doi: 10.1097/MD.0000000000023249.
4
Conducting high quality scoping reviews-challenges and solutions.高质量范围综述的实施:挑战与解决方案。
J Clin Epidemiol. 2021 Feb;130:156-160. doi: 10.1016/j.jclinepi.2020.10.009. Epub 2020 Oct 26.
5
[The importance of evaluation of gastrointestinal symptoms in advanced Parkinson’s disease].[晚期帕金森病中胃肠道症状评估的重要性]
Orv Hetil. 2020 Sep 27;161(39):1681-1687. doi: 10.1556/650.2020.31782.
6
Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBE.“5-2-1”筛查标准在晚期帕金森病中的应用:DUOGLOBE 的中期分析。
Neurodegener Dis Manag. 2020 Oct;10(5):309-323. doi: 10.2217/nmt-2020-0021. Epub 2020 Sep 2.
7
Levodopa-Carbidopa Intestinal Gel Infusion Therapy Discontinuation: A Ten-Year Retrospective Analysis of 204 Treated Patients.左旋多巴-卡比多巴肠凝胶输注疗法的停用:对204例接受治疗患者的十年回顾性分析。
Neuropsychiatr Dis Treat. 2020 Jul 28;16:1835-1844. doi: 10.2147/NDT.S256988. eCollection 2020.
8
Tolerability of non-ergot oral and transdermal dopamine agonists in younger and older Parkinson's disease patients: an European multicentre survey.非麦角类口服和透皮多巴胺激动剂在年轻和老年帕金森病患者中的耐受性:一项欧洲多中心调查。
J Neural Transm (Vienna). 2020 Jun;127(6):875-879. doi: 10.1007/s00702-020-02168-0. Epub 2020 May 5.
9
Does the Degree of Trunk Bending Predict Patient Disability, Motor Impairment, Falls, and Back Pain in Parkinson's Disease?帕金森病患者的躯干弯曲程度能否预测其残疾、运动障碍、跌倒及背痛情况?
Front Neurol. 2020 Mar 31;11:207. doi: 10.3389/fneur.2020.00207. eCollection 2020.
10
Profile Of Patients With Advanced Parkinson's disease Suitable For Device-Aided Therapies: Restrospective Data Of A Large Cohort Of Romanian Patients.适合器械辅助治疗的晚期帕金森病患者概况:罗马尼亚一大群患者的回顾性数据
Neuropsychiatr Dis Treat. 2019 Nov 13;15:3187-3195. doi: 10.2147/NDT.S230052. eCollection 2019.